Farmax India Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015
For the nine months, the company reported net sales/income from operations of INR 146.913 million against INR 130.670 million a year ago. Loss before tax was INR 92.027 million against INR 66.955 million a year ago. Net loss after tax & extraordinary items was INR 92.027 million against INR 66.955 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.17 against INR 0.16 a year ago.